Neuroinflammation in Parkinson’s Disease Animal Models: A Cell Stress Response or a Step in Neurodegeneration?
The DOI matches its Crossref record; 280 of the 282 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
The motor symptoms of Parkinson's disease are due to the progressive degeneration of dopaminergic neurons in the substantia nigra. Multiple neuroinflammatory processes are exacerbated in Parkinson's disease, including glial-mediated reactions, increased expression of proinflammatory substances, and lymphocytic infiltration, particularly in the substantia nigra. Neuroinflammation is also implicated in the neurodegeneration and consequent behavioral symptoms of many Parkinson's disease animal models, although it is not clear whether these features emulate pathogenic steps in the genuine disorder or if some inflammatory features provide protective stress responses. Here, we compare and summarize findings on neuroinflammatory responses and effects on behavior in a wide range of toxin-based, inflammatory and genetic Parkinson's disease animal models.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“α-Synuclein modified by ONOO− or oxidized dopamine forms aggregates and Lewy bodies (214) that further activate microglia (211).”
From Chemiexcitation: Mammalian Photochemistry in the Dark† (2023) · cites this paper as [214]
Citations
Cites
2 retracted
Accumulation of oligomer-prone α-synuclein exacerbates synaptic and neuronal degeneration in vivo
Rockenstein, E., Nuber, S., Overk, C. R., Ubhi, K., Mante, M., Patrick, C., Adame, A., Trejo-Morales, M., Gerez, J., Picotti, P., et al. (2014) · Brain · doi:10.1093/brain/awu057 · Cited by 238
RetractedTobón-Velasco, J. C., Limón-Pacheco, J. H., Orozco‐Ibarra, M., Macías‐Silva, M., Vázquez‐Victorio, G., Cuevas, E., Ali, S. F., Cuadrado, A., Pedraza‐Chaverrí, J., & Santamaría, A. (2012) · Toxicology · doi:10.1016/j.tox.2012.12.011 · Cited by 42
RetractedSpillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 2×
“SNCA was also the first PD gene identified (Polymeropoulos et al. 1997), and encodes a 140 amino acid synaptic vesicle-associated protein that regulates synaptic vesicle exocytosis (Abeliovich et al.”
BackgroundParkinson's disease: clinical features and diagnosis
Jankovic, J. (2008) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2007.131045 · Cited by 5,720 · cited 2×
“…by a progressive loss of dopamine (DA) releasing neurons in the substantia nigra (SN) pars compacta (SNc), resulting in slowness of movement, rigidity, and tremor (Jankovic 2008), as well as the death of neurons in other catecholaminergic and cholinergic nuclei (Sulzer and Surmeier 2013).”
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227 · cited 1×
“Mutations in the parkin gene, which encodes for an E3 ubiquitin ligase, are the leading cause of early-onset, autosomal recessive parkinsonism (Kitada et al. 1998; Hattori et al. 1998; Lücking et al. 2000).”
Backgroundα-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R., Sherer, T. B., MacKenzie, G., Garcia-Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,683
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Cited by
Selective neuronal vulnerability in Parkinson disease
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116
T cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., Cote, L., Kanter, E., Agin-Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature22815 · Cited by 866
Self-citationα-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease
Lindestam Arlehamn, C. S., Dhanwani, R., Pham, J., Kuan, R., Frazier, A., Rezende Dutra, J., Phillips, E., Mallal, S., Roederer, M., Marder, K. S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15626-w · Cited by 386
Self-citationWerry, E. L., Bright, F. M., Piguet, O., Ittner, L. M., Halliday, G. M., Hodges, J. R., Kiernan, M. C., Loy, C. T., Kril, J. J., & Kassiou, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20133161 · Cited by 279
Sulzer, D., Cassidy, C., Horga, G., Kang, U. J., Fahn, S., Casella, L., Pezzoli, G., Langley, J., Hu, X. P., Zucca, F. A., et al. (2018) · npj Parkinson's Disease · doi:10.1038/s41531-018-0047-3 · Cited by 270
Self-citationMicroglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson’s disease
George, S., Rey, N. L., Tyson, T., Esquibel, C., Meyerdirk, L., Schulz, E., Pierce, S., Burmeister, A. R., Madaj, Z., Steiner, J. A., et al. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0335-3 · Cited by 229
Wang, L., Zhao, Z., Zhao, L., Zhao, Y., Yang, G., Wang, C., Gao, L., Niu, C., & Li, S. (2022) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c07711 · Cited by 203
Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease
Troncoso-Escudero, P., Parra, A., Nassif, M., & Vidal, R. L. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00860 · Cited by 191
“Studies in experimental animal models of PD have shown that neuroinflammation plays a key role in disease progression (34).”
BackgroundBido, S., Muggeo, S., Massimino, L., Marzi, M. J., Giannelli, S. G., Melacini, E., Nannoni, M., Gambarè, D., Bellini, E., Ordazzo, G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26519-x · Cited by 190
Ghosh, A., Tyson, T., George, S., Hildebrandt, E. N., Steiner, J. A., Madaj, Z., Schulz, E., Machiela, E., McDonald, W. G., Escobar Galvis, M. L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag2210 · Cited by 189
Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration
Ghiglieri, V., Calabrese, V., & Calabresi, P. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2018.00295 · Cited by 159
Sun, H., Liang, R., Yang, B., Zhou, Y., Liu, M., Fang, F., Ding, J., Fan, Y., & Hu, G. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.01.003 · Cited by 124
Activation of the DNA damage response in vivo in synucleinopathy models of Parkinson’s disease
Milanese, C., Cerri, S., Ulusoy, A., Gornati, S. V., Plat, A., Gabriels, S., Blandini, F., Di Monte, D. A., Hoeijmakers, J. H., & Mastroberardino, P. G. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0848-7 · Cited by 118
Tentillier, N., Etzerodt, A., Olesen, M. N., Rizalar, F. S., Jacobsen, J., Bender, D., Moestrup, S. K., & Romero-Ramos, M. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1636-16.2016 · Cited by 109
Selective neuronal vulnerability in Parkinson's disease
(2020) · Progress in Brain Research · doi:10.1016/bs.pbr.2020.02.005 · Cited by 80
Xu, L., Wu, Y., Yan, F., Li, C., Dai, Z., You, Q., Jiang, Z., & Di, B. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.01.003 · Cited by 74
Are rodent models of Parkinson’s disease behaving as they should?
Vingill, S., Connor‐Robson, N., & Wade‐Martins, R. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.10.021 · Cited by 68
Singh, S., & Kumar, P. (2016) · Inflammopharmacology · doi:10.1007/s10787-016-0297-9 · Cited by 61
Zhu, Y., Liu, Z., Peng, Y.-P., & Qiu, Y. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.07.017 · Cited by 61
Heat shock protein 70 suppresses neuroinflammation induced by α-synuclein in astrocytes
Yu, W., Cao, S.-N., Zang, C., Wang, L., Yang, H., Bao, X.-Q., & Zhang, D. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.11.013 · Cited by 60
Tancheva, L. P., Lazarova, M. I., Alexandrova, A., Dragomanova, S., Nicoletti, F., Tzvetanova, E., Hodzhev, Y., Kalfin, R. E., Miteva, S., Mazzon, E., et al. (2020) · Antioxidants · doi:10.3390/antiox9010049 · Cited by 55
GPER Agonist G1 Attenuates Neuroinflammation and Dopaminergic Neurodegeneration in Parkinson Disease
Guan, J., Yang, B., Fan, Y., & Zhang, J. (2017) · Neuroimmunomodulation · doi:10.1159/000478908 · Cited by 53
Immune-related biomarkers for Parkinson's disease
Abdi, I. Y., Ghanem, S. S., & El‐Agnaf, O. M. A. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105771 · Cited by 44
Xu, L., Zhang, D., Shoji, H., Duan, C., Zhang, G., Isaji, T., Wang, Y., Fukuda, T., & Gu, J. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.12.008 · Cited by 43
Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation
Belloli, S., Morari, M., Murtaj, V., Valtorta, S., Moresco, R. M., & Gilardi, M. C. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00152 · Cited by 43
Widespread Tau-Specific CD4 T Cell Reactivity in the General Population
Lindestam Arlehamn, C. S., Pham, J., Alcalay, R. N., Frazier, A., Shorr, E., Carpenter, C., Sidney, J., Dhanwani, R., Agin-Liebes, J., Garretti, F., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801506 · Cited by 41
Self-citationChemiexcitation and Its Implications for Disease
Brash, D. E., Goncalves, L. C. P., & Bechara, E. J. H. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.04.004 · Cited by 36
Tang, H., Zheng, Z., Wang, H., Wang, L., Zhao, G., & Wang, P. (2022) · Nutrients · doi:10.3390/nu14071504 · Cited by 39
He, D., Huang, B., Fu, S., Li, Y., Ran, X., Liu, Y., Chen, G., Liu, J., & Liu, D. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082242 · Cited by 36
Corwin, C., Nikolopoulou, A., Pan, A. L., Nunez-Santos, M., Vallabhajosula, S., Serrano, P. A., Babich, J. W., & Figueiredo-Pereira, M. E. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1305-3 · Cited by 34
Avola, R., Graziano, A. C. E., Pannuzzo, G., Albouchi, F., & Cardile, V. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.02.006 · Cited by 33
Yang, C.-C., Lin, C., Jou, M., Hsiao, L., & Yang, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112826 · Cited by 31
Bal‐Price, A., Leist, M., Schildknecht, S., Monnet‐Tschudi, F., Paini, A., & Terron, A. (2018) · OECD series on adverse outcome pathways · doi:10.1787/b46c3c00-en · Cited by 28
Correia, A. O., Cruz, A. A. P., Aquino, A. T. R. D., Diniz, J. R. G., Santana, K. B. F., Cidade, P. I. M., Peixoto, J. D., Lucetti, D. L., Nobre, M. E. P., Cruz, G. M. P. D., et al. (2015) · Journal of Neurology and Therapeutics · doi:10.14312/2397-1304.2015-1 · Cited by 24
Erratum: T cells from patients with Parkinson’s disease recognize α-synuclein peptides
Sulzer, D., Alcalay, R. N., Garretti, F., COTE, L. J., Kanter, E., Agin‐Liebes, J., Liong, C., McMurtrey, C., Hildebrand, W. H., Mao, X., et al. (2017) · Nature · doi:10.1038/nature23896 · Cited by 23
Self-citationZhang, C., Zhou, J., Zhuo, L., Zhang, W., Lv, L., Zhu, L., Zhang, J., Feng, F., Liu, W., Han, L., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118391 · Cited by 20
Porrini, V., Mota, M., Parrella, E., Bellucci, A., Benarese, M., Faggi, L., Tonin, P., Spano, P., & Pizzi, M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00229 · Cited by 20
Jiang, M., Chen, Y., Li, L., Xu, L., Liu, H., Qu, X., Xu, J., Ge, B.-B., & Qu, H. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7352 · Cited by 17
Chemiexcitation: Mammalian Photochemistry in the Dark†
Brash, D. E., & Goncalves, L. C. P. (2023) · Photochemistry and Photobiology · doi:10.1111/php.13781 · Cited by 16
Feng, S., Chuang, H., Yeh, K., & Pan, S. (2021) · Arthritis Care & Research · doi:10.1002/acr.24708 · Cited by 16
Alpha-synuclein and cortico-striatal plasticity in animal models of Parkinson disease
Marino, G., Calabresi, P., & Ghiglieri, V. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819410-2.00008-4 · Cited by 16
Stutz, B., Nasrallah, C. M., Nigro, M., Curry, D. W., Liu, Z.-W., Gao, X., Elsworth, J. D., Mintz, L., & Horváth, T. L. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.02.005 · Cited by 15
Ng, L., Wang, X., Yang, C., Su, C.-F., Li, M., & Cheung, A. K. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.833515 · Cited by 15
Higher risk of Parkinson disease in patients with primary Sjögren’s syndrome
Hsu, H., Hou, T., Lin, T.-M., Chang, Y.-S., Chen, W., Kuo, P., Lin, Y.-C., Chang, C., & Chen, J. H. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05053-z · Cited by 14
Wee, I. C., Arulsamy, A., Corrigan, F., & Collins‐Praino, L. E. (2024) · Molecules · doi:10.3390/molecules29071470 · Cited by 13
Spittau, B. (2015) · Neural Regeneration Research · doi:10.4103/1673-5374.165228 · Cited by 12
Heng, H., Liu, J., Hu, M., Li, D., Su, W., & Li, J. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.1013745 · Cited by 11
Li, Y., Yu, C., Jiang, X., Fu, J., Sun, N., & Zhang, D. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155349 · Cited by 9
Parekh, P., Serra, M., Allaw, M., Perra, M., Pinna, A., Manconi, M., & Morelli, M. (2024) · Experimental Neurology · doi:10.1016/j.expneurol.2024.114958 · Cited by 8
Ross, A., Prowse, N., Zhang, H., Hayley, S., & Sun, H. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1627305 · Cited by 6
Mack, J. M., Moura, T. D. M., Bobinski, F., Martins, D. F., Cunha, R. A., Walz, R., Fernandes, P. A. C. M., Markus, R. P., Dafré, A. L., & Prediger, R. D. (2020) · NeuroToxicology · doi:10.1016/j.neuro.2020.07.008 · Cited by 6
Inflammation: Role in Parkinson's Disease and Target for Therapy
Flood, P. M., Arbabzada, N., & Sharma, M. (2016) · InTech eBooks · doi:10.5772/63164 · Cited by 6
Gargiulo, S., Coda, A. R. D., Panico, M., Gramanzini, M., Moresco, R. M., Chalon, S., & Pappatà, S. (2017) · The Quarterly Journal of Nuclear Medicine and Molecular Imaging · doi:10.23736/s1824-4785.16.02948-4 · Cited by 6
TSPO PET Imaging as a Biomarker of Neuroinflammation in Neurodegenerative Disorders
Werry, E. L., Bright, F., & Kassiou, M. (2021) · Neuromethods · doi:10.1007/978-1-0716-1712-0_17 · Cited by 6
Co-signaling Molecules in Neurological Diseases
Kivisäkk, P., & Khoury, S. J. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9717-3_9 · Cited by 5
Du, K., Zuo, Y.-L., Zhang, Z.-M., Li, A., Zuo, Q., Zhang, C., Guo, R., Chen, P., Du, W.-S., & Li, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-97428-y · Cited by 4
Lim, J. S., Li, X., Lee, D. Y., Yao, L., Yoo, G., Kim, Y. W., Eum, S. M., Cho, Y.-C., Yoon, S., & Park, S.-J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051932 · Cited by 4
Hu, Y. C., Zhang, K., Paul, K. C., Zhou, J., Bronstein, J. M., Kusters, C., & Ritz, B. R. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.101014 · Cited by 4
Changes in the Immune System in Parkinson’s Disease
Romero‐Ramos, M. (2017) · Springer eBooks · doi:10.1007/978-3-319-64597-1_150-1 · Cited by 1
Corwin, C. (2018) · CUNY Academic Works (City University of New York) · Cited by 1
Mack, J. M. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Parkin Protein: The Missing Link Between Cardiovascular and Parkinson’s Disease
Bagchi, A. (2019) · Springer eBooks · doi:10.1007/978-981-13-8946-7_20
Monika (2019) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-bdqm-y581
EFFECTS OF THE G2019S LRRK2 MUTATION ON MOTOR LEARNING IN MICE
Wholford, L. A. (2018)
Nazario, L. R. (2020) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.130756082
Changes in the Immune System in Parkinson’s Disease
Romero‐Ramos, M. (2019) · Springer eBooks · doi:10.1007/978-3-319-99375-1_150
Faustini, G., Mazzocco, M. T., Comelli, A., Brugnoli, A., Benfante, V., Brembati, V., Longhena, F., Gennari, M. M., Coliva, A., Magnino, S., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6502918/v1
Sahil (2025) · International Journal For Multidisciplinary Research · doi:10.36948/ijfmr.2025.v07i06.62276
Maladie de Parkinson et DMLA : y a-t-il un lien ?
Mathis, T. (2020) · theses.fr (ABES) · doi:10.70675/fa69dd3ez4363z4b07zba8aze1d5251d827b
Natale, G., Carluccio, M. D., Campanelli, F., Marino, G., Nutarelli, S., Servillo, F., Canonichesi, J., Lentini, N., Pastorino, R., Chiurchiù, V., et al. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115942
Ng, L., Wang, X., Yang, C., Su, C., Li, M., & Cheung, A. K. L. (2022) · doi:10.3389/fimmu.2022.833515.s002
Metadata
- Authors
- Cebrián, C., Loike, J. D., & Sulzer, D.
- Affiliations
- Columbia University Irving Medical Center (US)
- Corresponding author
- Sulzer, David
- Venue
- Current Topics in Behavioral Neurosciences
- Publisher
- Springer Berlin Heidelberg
- Published
- 2014
- Volume
- 22
- Pages
- 237-270
- ISSN
- 1866-3370 (ISSN-L)
- 1866-3389
- OpenAlex
- W2120150976
- Cited by
- 65
- References
- 282
- Citations by year
- 2025: 5 · 2024: 4 · 2023: 1 · 2022: 6 · 2021: 3 · 2020: 7 · 2019: 10 · 2018: 12 · 2017: 10 · 2016: 5 · 2015: 2
- FWCI
- 12.15
- Type
- book chapter
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Current topics in behavioral neurosciences (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (P50NS038370)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- Parkinson's disease, neuroinflammation, neurodegeneration, dopaminergic neurons, substantia nigra, glial activation, inflammatory cytokines, lymphocyte infiltration, cellular stress response, genetic animal models, behavioral symptoms
- MeSH terms
- Animals, Disease Models, Animal, Inflammation, Parkinson Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.